191 related articles for article (PubMed ID: 37936974)
41. Primary anaplastic large cell lymphomas of the pancreas.
Chen L; Krause JR; Zhang H
Proc (Bayl Univ Med Cent); 2022; 35(5):675-677. PubMed ID: 35991749
[TBL] [Abstract][Full Text] [Related]
42. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
[TBL] [Abstract][Full Text] [Related]
43. A challenging case of ALK-negative anaplastic large cell lymphoma in a 12-year-old boy: A rare case report from Syria.
Abdul Rahman SA; Loutfi K; Turk T; Rahman AA; Kherbek H; Ghanem A; Alshehabi Z
Ann Med Surg (Lond); 2022 Jul; 79():104085. PubMed ID: 35860076
[TBL] [Abstract][Full Text] [Related]
44. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma.
Wang X; Wu J; Zhang M
Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226
[TBL] [Abstract][Full Text] [Related]
45. Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
Zhang W; Burton S; Wu S; Qian X; Rajeh MN; Schroeder K; Shuldberg M; Merando A; Lai JP
In Vivo; 2017; 31(4):701-704. PubMed ID: 28652442
[TBL] [Abstract][Full Text] [Related]
46. Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
Agrusa JE; Egress ER; Lowe EJ
Front Immunol; 2023; 14():1203471. PubMed ID: 37275877
[TBL] [Abstract][Full Text] [Related]
47. Clinical presentation of anaplastic large-cell lymphoma in the central nervous system.
Nomura M; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maruyama T; Muragaki Y; Shibui S
Mol Clin Oncol; 2013 Jul; 1(4):655-660. PubMed ID: 24649224
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
[TBL] [Abstract][Full Text] [Related]
49. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
[TBL] [Abstract][Full Text] [Related]
50. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl.
Ju E; Adigun C; Dunphy C; Gold S; Morrell DS
Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522
[TBL] [Abstract][Full Text] [Related]
51. ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy.
Tian C; Yu Y; Yang H; Zhu L; Wang Y; Zhang Y
Onco Targets Ther; 2016; 9():265-8. PubMed ID: 26834485
[TBL] [Abstract][Full Text] [Related]
52. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
[TBL] [Abstract][Full Text] [Related]
53. Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature.
Cavanna L; Grassi SO; Ruffini L; Michieletti E; Carella E; Palli D; Zangrandi A; Inzerilli N; Bernuzzi P; Di Nunzio C; Citterio C
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676781
[TBL] [Abstract][Full Text] [Related]
54. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.
Kodama K; Hokama M; Kawaguchi K; Tanaka Y; Hongo K
Neuropathology; 2009 Apr; 29(2):166-71. PubMed ID: 18564100
[TBL] [Abstract][Full Text] [Related]
55. ALK-negative anaplastic large cell lymphoma with "Hodgkin-like" cytomorphology and nuclear expression of PAX5.
Fratoni S; Niscola P; Zhao XF; Larocca LM; Capalbo A; Fabbretti M; Bernardini L; Abruzzese E
Pathol Res Pract; 2020 Feb; 216(2):152724. PubMed ID: 31784094
[TBL] [Abstract][Full Text] [Related]
56. ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature.
Lannon M; Lu JQ; Chum M; Wang BH
Br J Neurosurg; 2023 Oct; 37(5):1245-1250. PubMed ID: 33253051
[TBL] [Abstract][Full Text] [Related]
57. [Clinical characteristics and prognostic factors of 40 cases of primary systemic anaplastic large cell lymphoma].
Chen YK; Yu WJ; Liu H; Wei JY; Qian WB; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):222-227. PubMed ID: 32311892
[No Abstract] [Full Text] [Related]
58. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
Magro CM; Momtahen S; Kiuru M
Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
[TBL] [Abstract][Full Text] [Related]
59. Second allogeneic transplantation using umbilical cord blood for a patient with relapsed ALK+ anaplastic large cell lymphoma after allogeneic bone marrow transplantation in the era of ALK inhibitors: A case report.
Saito S; Tashiro H; Sumiyoshi R; Matsuo T; Yamamoto T; Matsumoto K; Ooi J; Shirafuji N
Medicine (Baltimore); 2021 Apr; 100(15):e25576. PubMed ID: 33847688
[TBL] [Abstract][Full Text] [Related]
60. Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.
Akilov OE; Pillai RK; Grandinetti LM; Kant JA; Geskin L
Arch Dermatol; 2011 Aug; 147(8):943-7. PubMed ID: 21844453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
